A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy
Authors:
- 12 March 2013
- journal article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 14 (1) , 20-27
Abstract
We conducted a genome-wide association study (GWAS) to identify single nucleotide polymorphisms (SNPs) influencing overall survival (OS) of small-cell lung cancer (SCLC) patients. We prospectively collected blood samples from 139 SCLC patients who participated in phase II studies of irinotecan and cisplatin (IP) chemotherapy as first-line therapy. Among 334 127 SNPs, which passed quality control, seven showed significant association with OS. The rs16950650CT, rs7186128AG or GG, rs17574269AG, rs8020368CC, rs4655567CC, rs2166219TT or rs2018683TT showed shorter OS compared with control alleles. Among the seven SNPs, rs4655567, rs8020368 and rs2018683 were significantly associated with a resistant relapse (RR). In the multivariate analysis, rs8020368CC was significantly associated with higher risk of RR (odds ratio=16.7, P=0.007). In vitro and in silico analysis showed that SNPs in C14orf49 might be associated with epithelial-to-mesenchymal transition. This exploratory GWAS identified candidate SNPs that may be predictive of the clinical outcome of SCLC patients receiving IP.Keywords
This publication has 21 references indexed in Scilit:
- The nuclear envelope environment and its cancer connectionsNature Reviews Cancer, 2012
- Cytoskeletal Interactions at the Nuclear Envelope Mediated by NesprinsInternational Journal of Cell Biology, 2012
- Nesprin-3: a versatile connector between the nucleus and the cytoskeletonBiochemical Society Transactions, 2011
- Small cell lung cancer: new clinical recommendations and current status of biomarker assessmentEuropean Journal of Cancer, 2011
- A phase 2 study of irinotecan, cisplatin, and simvastatin for untreated extensive‐disease small cell lung cancerCancer, 2010
- Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124Journal of Clinical Oncology, 2009
- Randomized Phase II Study of Maintenance Irinotecan Therapy Versus Observation Following Induction Chemotherapy with Irinotecan and Cisplatin in Extensive Disease Small Cell Lung CancerJournal of Thoracic Oncology, 2008
- The Consensus Coding Sequences of Human Breast and Colorectal CancersScience, 2006
- Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results DatabaseJournal of Clinical Oncology, 2006
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000